Hypofractionated radiation therapy for early breast cancer and regional nodal irradiation-the jury is still out

Hilde Van Parijs; Nele Adriaenssens; Claire Verschraegen; Zineb Dahbi; Vincent Vinh-Hung; Guy Storme; Mark De Ridder; Nam P. Nguyen

doi:10.21037/tcr.2018.04.25

Hypofractionated radiation therapy for early breast cancer and regional nodal irradiation-the jury is still out

Hilde Van Parijs, Nele Adriaenssens, Claire Verschraegen, Zineb Dahbi, Vincent Vinh-Hung, Guy Storme, Mark De Ridder, Nam P. Nguyen

Onderzoeksoutput: Editorial

Samenvatting

Abstract
A recent study on the shoulder-arm morbidity of the breast cancer UK START trials in axillary node positive women argues that hypofractionated lymph node radiation therapy is safe, as the long-term complications rates such as arm edema and shoulder stiffness remained low at 10-year follow-up (1). Can the authors’ conclusions apply to all patients with breast cancer who require lymph nodes irradiation after lumpectomy or mastectomy? Is hypofractionation really safe?

Originele taal-2	English
Pagina's (van-tot)	S584-S586
Tijdschrift	Translational Cancer Research
Volume	7
DOI's	https://doi.org/10.21037/tcr.2018.04.25
Status	Published - 2018

Toegang tot document

10.21037/tcr.2018.04.25

Handle.net

Permanente koppeling

Andere bestanden en links

Link to publication in Scopus

Citeer dit

@article{e3a73aa264f942e2a7d372e5f5fcc0a4,

title = "Hypofractionated radiation therapy for early breast cancer and regional nodal irradiation-the jury is still out",

abstract = "AbstractA recent study on the shoulder-arm morbidity of the breast cancer UK START trials in axillary node positive women argues that hypofractionated lymph node radiation therapy is safe, as the long-term complications rates such as arm edema and shoulder stiffness remained low at 10-year follow-up (1). Can the authors{\textquoteright} conclusions apply to all patients with breast cancer who require lymph nodes irradiation after lumpectomy or mastectomy? Is hypofractionation really safe?",

author = "{Van Parijs}, Hilde and Nele Adriaenssens and Claire Verschraegen and Zineb Dahbi and Vincent Vinh-Hung and Guy Storme and {De Ridder}, Mark and Nguyen, {Nam P.}",

year = "2018",

doi = "10.21037/tcr.2018.04.25",

language = "English",

volume = "7",

pages = "S584--S586",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "Society for Translational Medicine (STM)",

}

TY - JOUR

T1 - Hypofractionated radiation therapy for early breast cancer and regional nodal irradiation-the jury is still out

AU - Van Parijs, Hilde

AU - Adriaenssens, Nele

AU - Verschraegen, Claire

AU - Dahbi, Zineb

AU - Vinh-Hung, Vincent

AU - Storme, Guy

AU - De Ridder, Mark

AU - Nguyen, Nam P.

PY - 2018

Y1 - 2018

N2 - AbstractA recent study on the shoulder-arm morbidity of the breast cancer UK START trials in axillary node positive women argues that hypofractionated lymph node radiation therapy is safe, as the long-term complications rates such as arm edema and shoulder stiffness remained low at 10-year follow-up (1). Can the authors’ conclusions apply to all patients with breast cancer who require lymph nodes irradiation after lumpectomy or mastectomy? Is hypofractionation really safe?

AB - AbstractA recent study on the shoulder-arm morbidity of the breast cancer UK START trials in axillary node positive women argues that hypofractionated lymph node radiation therapy is safe, as the long-term complications rates such as arm edema and shoulder stiffness remained low at 10-year follow-up (1). Can the authors’ conclusions apply to all patients with breast cancer who require lymph nodes irradiation after lumpectomy or mastectomy? Is hypofractionation really safe?

UR - http://www.scopus.com/inward/record.url?scp=85048210254&partnerID=8YFLogxK

U2 - 10.21037/tcr.2018.04.25

DO - 10.21037/tcr.2018.04.25

M3 - Editorial

AN - SCOPUS:85048210254

SN - 2218-676X

VL - 7

SP - S584-S586

JO - Translational Cancer Research

JF - Translational Cancer Research

ER -